Molecular Testing for Cystic Fibrosis Carrier Status Practice Guidelines: Recommendations of the National Society of Genetic Counselors
Open Access
- 7 September 2013
- journal article
- research article
- Published by Wiley in Journal of Genetic Counseling
- Vol. 23 (1) , 5-15
Abstract
Purpose: To provide practice recommendations for genetic counselors whose clients are considering cystic fibrosis (CF) carrier testing or seeking information regarding CF molecular test results. The goals of these recommendations are to: 1) Provide updated information about the natural history, diagnosis, and treatment of CF and related conditions. 2) Supplement genetic counselors’ knowledge and understanding of the available carrier screening and diagnostic testing options. 3) Describe the current state of genotype/phenotype correlations forCFTRmutations and an approach to interpreting both novel and previously described variants. 4) Provide a framework for genetic counselors to assist clients’ decision‐making regarding CF carrier testing, prenatal diagnosis, and pregnancy management.DisclaimerThe practice guidelines of the National Society of Genetic Counselors (NSGC) are developed by members of the NSGC to assist genetic counselors and other health care providers in making decisions about appropriate management of genetic concerns; including access to and/or delivery of services. Each practice guideline focuses on a clinical or practice‐based issue, and is the result of a review and analysis of current professional literature believed to be reliable. As such, information and recommendations within the NSGC practice guidelines reflect the current scientific and clinical knowledge at the time of publication, are only current as of their publication date, and are subject to change without notice as advances emerge.In addition, variations in practice, which take into account the needs of the individual patient and the resources and limitations unique to the institution or type of practice, may warrant approaches, treatments and/or procedures that differ from the recommendations outlined in this guideline. Therefore, these recommendations should not be construed as dictating an exclusive course of management, nor does the use of such recommendations guarantee a particular outcome. Genetic counseling practice guidelines are never intended to displace a health care provider's best medical judgment based on the clinical circumstances of a particular patient or patient population.Practice guidelines are published by NSGC for educational and informational purposes only, and NSGC does not “approve” or “endorse” any specific methods, practices, or sources of information.Keywords
This publication has 68 references indexed in Scilit:
- Clinical Care Guidelines for Cystic Fibrosis–Related DiabetesDiabetes Care, 2010
- A Tailored Approach to Family‐Centered Genetic Counseling for Cystic Fibrosis Newborn Screening: The Wisconsin ModelJournal of Genetic Counseling, 2010
- Cystic Fibrosis Foundation Practice Guidelines for the Management of Infants with Cystic Fibrosis Transmembrane Conductance Regulator-Related Metabolic Syndrome during the First Two Years of Life and BeyondThe Journal of Pediatrics, 2009
- Emerging Treatments in Cystic FibrosisDrugs, 2009
- Clinical practice and genetic counseling for cystic fibrosis and CFTR-related disordersGenetics in Medicine, 2008
- Update on gene modifiers in cystic fibrosisCurrent Opinion in Pulmonary Medicine, 2008
- Best practice guidelines for molecular genetic diagnosis of cystic fibrosis and CFTR-related disorders – updated European recommendationsEuropean Journal of Human Genetics, 2008
- Guidelines for Diagnosis of Cystic Fibrosis in Newborns through Older Adults: Cystic Fibrosis Foundation Consensus ReportThe Journal of Pediatrics, 2008
- Consensus on the use and interpretation of cystic fibrosis mutation analysis in clinical practiceJournal of Cystic Fibrosis, 2008
- Heritability of Lung Disease Severity in Cystic FibrosisAmerican Journal of Respiratory and Critical Care Medicine, 2007